Peroxisome proliferator activator receptor (ppar)- ? ligand, but not ppar- ? , ameliorates cyclophosphamide-induced oxidative stress and inflammation in rat liver

HIGHLIGHTS

• who: Peroxisome Proliferator Activator Receptor and colleagues from the Department of Pharmacology, Faculty of Medicine, Minia University, Minia, Egypt have published the Article: Peroxisome Proliferator Activator Receptor (PPAR)- 𝛾 Ligand, but Not PPAR- 𝛼 , Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver, in the Journal: (JOURNAL) of 31/08/2013
• what: The aim of this study is to establish the potential use of PPAR-𝛼 and -𝛾 agonists, FEN, and PIO, respectively, as supplementary adjuvant to protect against CP-induced hepatotoxicity and to investigate the pharmacological mechanisms involved.
• future: Future studies are necessary to prove . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.